trending Market Intelligence /marketintelligence/en/news-insights/trending/-eV5saKrkboLZ0lku4vQAg2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In this list

Stryker acquires Israeli medical-device maker to bolster sports therapy segment

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Stryker acquires Israeli medical-device maker to bolster sports therapy segment

Stryker Corp. completed the acquisition of privately held OrthoSpace Ltd. for an upfront cash payment of $110 million to bolster its sports therapy portfolio.

The Kalamazoo, Mich.-based medical-device maker, Stryker, will also pay an additional $110 million in milestone payments to OrthoSpace.

Stryker said the acquisition is complementary to its existing portfolio and aligns with its focus on investing in sports medicine.

Israel-based OrthoSpace's product portfolio uses a differentiated technology for treating massive irreparable rotator cuff tears — a group of muscles and tendons that surround the shoulder joint. Rotator cuff injuries occur more often in people who perform overhead motions in their jobs or sports.

OrthoSpace's product InSpace, which is in development and not approved in the U.S., is a biodegradable implant that is designed to realign the natural biomechanics of the shoulder.

Stryker said the transaction is expected to have little effect on its net earnings for 2019.